New Delhi: A new variant of the coronavirus, identified as XEC, is rapidly gaining tractionacross the globe, according to recent reports.The XEC strain, a hybrid of the KS.1.1 and KP.3.3 variants, was first identified in
Read More
London: Fulcrum Therapeutics announced on Thursday that its investigational treatment fora muscle disorder did not meet the primary objective in a pivotal late-stage trial, resulting in anearly 70% drop in the company’s stock before the
Read More
A study published in Regional Anesthesia and Pain Medicine has linked higher levels ofabdominal fat, particularly visceral fat around internal organs, with a greater likelihood ofexperiencing widespread chronic pain, particularly in women. The research, conducted
Read More
The U.S. Food and Drug Administration (FDA) has granted expanded approval for Johnson& Johnson’s Tremfya, allowing its use in treating adults with chronic inflammatory boweldisease (IBD), specifically ulcerative colitis. This marks a significant development, providingan
Read More
The Industrial Review is a beacon of recognition, spotlighting unsung heroes in the Indian business landscape. We address an acknowledgment deficit by championing excellence and inspiring recognition. Join us in rewriting the narrative of success, one achievement at a time.
General: info@theindustrialreview.com
tel: +91 84313 13579
